InsidersTradesSigma
Follow the 한국비엔씨 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 한국비엔씨 has recorded 1 public disclosures. Market capitalisation: €164.8bn. The latest transaction was reported on 27 March 2026 (Other). Among the most active insiders: 최완규. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
한국비엔씨 es una empresa que opera en el sector de la salud y farmacéutico, cotiza en el mercado XKRX. Se enfoca en el desarrollo y comercialización de productos farmacéuticos.